Last reviewed · How we verify

NCT03765320

Impact of Peritoneal Closure and Retroperitoneal Drainage on Patients Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection

Completed Last updated 22 October 2019
What this trial tests

trial testing Peritoneal closure in Lymphocele in 204 participants. Completed in 25 March 2019.

Timeline
6 November 2018
Primary endpoint
12 February 2019
25 March 2019

Quick facts

Lead sponsorFar Eastern Memorial Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment204
Start date6 November 2018
Primary completion12 February 2019
Estimated completion25 March 2019
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Far Eastern Memorial Hospital

Who can join

20 and older, female only, with Lymphocele or Gynecologic Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To elucidate whether peritoneal closure and retroperitoneal drainage can benefit clinical outcome of early gynecologic cancer patients who underwent retroperitoneal lymph node dissection.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Predictors of Lymphoceles in Women Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection for Early Gynecologic Cancer: A Retrospective Cohort Study.
    Chen HH, Ting WH, Lin HH, Hsiao SM. · · 2019 · cited 6× · PMID 30875912 · DOI 10.3390/ijerph16060936

Verify or expand the search:

Other recruiting trials for Lymphocele

Currently open trials in the same condition.

Other Far Eastern Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03765320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing